Aysooda Hosseinzadeh
Aysooda Hosseinzadeh
M.Sc. in Medical Immunology, Department of Immunology Faculty of Medicine Shahid Sadoughi University
Verified email at
Cited by
Cited by
Breast cancer: Biology, biomarkers, and treatments
K Barzaman, J Karami, Z Zarei, A Hosseinzadeh, MH Kazemi, ...
International immunopharmacology 84, 106535, 2020
Immunomodulatory effects of flavonoids: possible induction of T CD4+ regulatory cells through suppression of mTOR pathway signaling activity
A Hosseinzade, O Sadeghi, A Naghdipour Biregani, S Soukhtehzari, ...
Frontiers in immunology 10, 51, 2019
Breast cancer immunotherapy: Current and novel approaches
K Barzaman, S Moradi-Kalbolandi, A Hosseinzadeh, MH Kazemi, ...
International immunopharmacology 98, 107886, 2021
Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER
S Moradi-Kalbolandi, A Hosseinzade, M Salehi, P Merikhian, ...
Journal of Pharmacy and Pharmacology 70 (7), 841-854, 2018
Estrogen can restore Tamoxifen sensitivity in breast cancer cells amidst the complex network of resistance
S Mansouri, L Farahmand, A Hosseinzade, Z Eslami-S, K Majidzadeh-A
Biomedicine & Pharmacotherapy 93, 1320-1325, 2017
MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy
A Hosseinzadeh, P Merikhian, N Naseri, MR Eisavand, L Farahmand
Cancer Cell International 22 (1), 110, 2022
ER-α36 interactions with cytosolic molecular network in acquired tamoxifen resistance
A Teymourzadeh, S Mansouri, L Farahmand, A Hosseinzade, ...
Clinical breast cancer 17 (6), 403-407, 2017
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk
K Barzaman, R Vafaei, M Samadi, MH Kazemi, A Hosseinzadeh, ...
Cancer Cell International 22 (1), 259, 2022
Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study
R Vafaei, M Samadi, A Hosseinzadeh, K Barzaman, MR Esmailinejad, ...
Cancer Cell International 22, 1-9, 2022
& Farahmand, L.(2020)
K Barzaman, J Karami, Z Zarei, A Hosseinzadeh, MH Kazemi, ...
Breast cancer: Biology, biomarkers, and treatments. International …, 0
Flavonoids target different molecules of autophagic and metastatic pathways in cancer cells
A Hosseinzadeh, F Poursoleiman, AN Biregani, A Esmailzadeh
Cancer Cell International 23 (1), 114, 2023
Anti–MUC1 nanobody can synergize the Tamoxifen and Herceptin effects on breast cancer cells by inducing ER, PR and HER2 overexpression
MS Barough, N Jalili, S Shafiee, M Salehi, N Naseri, MA Javidi, ...
International Immunopharmacology 124, 110792, 2023
Metabolism plays the key roles in Th cells differentiation
A Hosseinzadeh, S Soukhtehzari, M Ghaedi, R Mansouri
Reumatismo 68 (4), 176-182, 2016
The system can't perform the operation now. Try again later.
Articles 1–13